Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)

Summary by The Toronto Star
Durham, N.C., May 11, 2026 (GLOBE NEWSWIRE) -

2 Articles

The Toronto StarThe Toronto Star
Reposted by
The Hamilton SpectatorThe Hamilton Spectator
Lean Left

First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)

Durham, N.C., May 11, 2026 (GLOBE NEWSWIRE) -

·Toronto, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada on Monday, May 11, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Durham, North Carolina icon

Durham, North Carolina

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal